Update of Metal-Based Drugs : Problems and Approaches for Solution

被引:0
|
作者
Huang Meiling [1 ]
Wu Yaling [1 ]
Zhao Pan [1 ]
Yang Xiaoda [1 ]
机构
[1] Peking Univ, Hlth Sci Ctr, Sch Pharmaceut Sci, Dept Biol Chem, Beijing 100191, Peoples R China
关键词
anti-cancer; antidiabetic; cisplatin; vanadium; DNA-BINDING PROPERTIES; INSULIN-MIMETIC AGENT; CELL-CYCLE ARREST; VANADIUM COMPOUNDS; PLATINUM COMPLEX; OXOVANADIUM(IV) COMPLEXES; SKELETAL-MUSCLE; GENE-EXPRESSION; DIABETIC-RATS; CANCER-CELLS;
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
From this century, great progresses have been made in the field of metal-based medicine and relevant fundamental researches. However, there are also major problems left to be solved. This review summarized the recent progresses and the bottlenecks of two important metal drugs, anti-cancer platinum/non-platinum drugs and anti-diabetic vanadium compounds. The following aspects are proposed for attentions in the future research: (1) Discover new molecular mechanism of metal drugs for rational design of metal drugs; (2) Control of metal toxicity based on molecular mechanism; (3) Rational metal drug design and metal drug delivery system based on nano materials, molecular complexes and drug transporters; (4) Synthetic biology of metal complexes.
引用
收藏
页码:650 / 660
页数:11
相关论文
共 115 条
  • [1] Bis(allixinato)oxovanadium(IV) complex is a potent antidiabetic agent: Studies on structure-activity relationship for a series of hydroxypyrone-vanadium complexes
    Adachi, Yusuke
    Yoshida, Jiro
    Kodera, Yukihiro
    Katoh, Akira
    Takada, Jitsuya
    Sakurai, Hiromu
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (11) : 3251 - 3256
  • [2] [Anonymous], 2012, BIOCH BIOPHYS ACTA, V1823
  • [3] [Anonymous], 2011, METALLOMICS, V3
  • [4] Aureliano Manuel, 2011, World J Biol Chem, V2, P215
  • [5] Nicotine attenuates spatial learning deficits induced by sodium metavanadate
    Azami, Kian
    Tabrizian, Kaveh
    Hosseini, Rohollah
    Seyedabadi, Mohammad
    Shariatpanahi, Marjan
    Noorbakhsh, Farshid
    Kebriaeezadeh, Abbas
    Ostad, Seyed Nasser
    Sharifzadeh, Mohammad
    [J]. NEUROTOXICOLOGY, 2012, 33 (01) : 44 - 52
  • [6] Approaching tumour therapy beyond platinum drugs Status of the art and perspectives of ruthenium drug candidates
    Bergamo, A.
    Gaiddon, C.
    Schellens, J. H. M.
    Beijnen, J. H.
    Sava, G.
    [J]. JOURNAL OF INORGANIC BIOCHEMISTRY, 2012, 106 (01) : 90 - 99
  • [7] Fatal poisoning by vanadium
    Boulassel, Brahim
    Sadeg, Nouredine
    Roussel, Olivier
    Perrin, Martine
    Belhadj-Tahar, Hafid
    [J]. FORENSIC SCIENCE INTERNATIONAL, 2011, 206 (1-3) : E79 - E81
  • [8] Aqueous chemistry of the vanadiumIII (VIII) and the VIII-dipicolinate systems and a comparison of the effect of three oxidation states of vanadium compounds on diabetic hyperglycemia in rats
    Buglyó, P
    Crans, DC
    Nagy, EM
    Lindo, RL
    Yang, LQ
    Smee, JJ
    Jin, WZ
    Chi, LH
    Godzala, ME
    Willsky, GR
    [J]. INORGANIC CHEMISTRY, 2005, 44 (15) : 5416 - 5427
  • [9] Metal complexes in medicine with a focus on enzyme inhibition
    Che, Chi-Ming
    Siu, Fung-Ming
    [J]. CURRENT OPINION IN CHEMICAL BIOLOGY, 2010, 14 (02) : 255 - 261
  • [10] Multi hydroxylated [Gd@C82(OH)22]n nanoparticles:: Antineoplastic activity of high efficiency and low toxicity
    Chen, CY
    Xing, GM
    Wang, JX
    Zhao, YL
    Li, B
    Tang, J
    Jia, G
    Wang, TC
    Sun, J
    Xing, L
    Yuan, H
    Gao, YX
    Meng, H
    Chen, Z
    Zhao, F
    Chai, ZF
    Fang, XH
    [J]. NANO LETTERS, 2005, 5 (10) : 2050 - 2057